Charles Goldsmith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charles Goldsmith has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Franco DeNardi
Department of Pathology and Molecular Medicine, McMaster University, Henderson General Hospital, 711 Concession Street, Hamilton, Ontario, L8V 1C3, Canada
1 shared publication - Lehana Thabane
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
1 shared publication - Mark Levine
Lancaster University
1 shared publication - Marko Simunovic
Juravinski Cancer Centre, 699 Concession St., Hamilton, Ontario, L8V 5C2, Canada
1 shared publication - Robin McLeod
Division of General Surgery, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada
1 shared publication - Timothy Joseph Whelan
Cancer Care Ontario, Hamilton, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 15 February 2008
- Published by Springer Nature in BMC Surgery
- Vol. 8 (1) , 4
The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery
Two unfortunate outcomes for patients treated surgically for rectal cancer are placement of a permanent colostomy and local tumor recurrence. Total mesorectal excision is a new technique for rectal cancer surgery that can lead to improved patient outcomes. We describe a cluster randomized controlled trial that is testing if the above patient outcomes can be improved through a knowledge translation strategy called the Quality Initiative in Rectal Cancer (QIRC) strategy. The strategy is designed to optimize the use of total mesorectal excision techniques.
- 15 February 2008
- Published by Springer Nature in BMC Surgery
- Vol. 8 (1) , 4
Open AccessThe Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery
Two unfortunate outcomes for patients treated surgically for rectal cancer are placement of a permanent colostomy and local tumor recurrence. Total mesorectal excision is a new technique for rectal cancer surgery that can lead to improved patient outcomes. We describe a cluster randomized controlled trial that is testing if the above patient outcomes can be improved through a knowledge translation strategy called the Quality Initiative in Rectal Cancer (QIRC) strategy. The strategy is designed to optimize the use of total mesorectal excision techniques.